This is a non-core endpoint: only basic statistics are computed.
Carcinoma in situ of vulva
CD2_INSITU_VULVA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleonly females |
293218 |
2. Check conditions
|
292887 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
294 |
4. Check minimum number of eventsNone |
294 |
5. Include endpointsNone |
294 |
6. Filter based on genotype QC (FinnGen only) |
278 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D07
- Name in latin
- Carcinoma in situ penis
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of vulva
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of other and unspecified genital organs
- In situ neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 278 | 278 | - |
| Unadjusted period prevalence (%) | 0.10 | 0.10 | - |
| Median age at first event (years) | 59.06 | 59.06 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 294
- Matched controls
- 2940
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
168.1
307.7
221
52
ULA02
NOMESCO Finland
Kolposcopy
99.7
306.3
261
216
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
1483.3
210.4
180
*
8077/2-C51.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vulva, NOS
+∞
206.4
173
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
19.7
153.4
204
304
LEB00
NOMESCO Finland
Biopsy of vagina
39.8
120.2
77
26
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
214.2
119.6
117
9
D06BB10
ATC
imiquimod; topical
19.2
110.7
100
77
N90.1
ICD-10 Finland
Moderate vulvar dysplasia
678.5
101.0
94
*
D07.1
ICD-10 Finland
Carcinoma in situ: Vulva
+∞
99.8
90
*
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
63.0
92.3
52
10
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
11.1
77.8
101
132
LFC00
NOMESCO Finland
Partial excision of vulva
327.9
76.3
74
*
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
10.8
52.9
64
74
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
6.8
51.5
105
221
A63.0
ICD-10 Finland
Anogenital (venereal) warts
13.1
47.0
48
43
D07AD01
ATC
clobetasol; topical
5.0
38.9
118
345
LDA10
NOMESCO Finland
Curettage of cervix uteri
8.2
38.9
58
86
N87.0
ICD-10 Finland
Mild cervical dysplasia
11.4
35.3
39
39
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
13.6
33.8
33
27
N90.0
ICD-10 Finland
Mild vulvar dysplasia
95.8
31.5
34
*
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
8.1
31.0
45
64
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.7
26.6
173
825
8070/2-C51.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of vulva, NOS
+∞
26.5
25
*
8071/2-C51.9
ICD-O-3
Differentiated intraepithelial neoplasia of vulva, NOS
+∞
23.2
22
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
4.7
22.1
59
150
8077/2-C52.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vagina, NOS
+∞
20.0
19
*
N76.6
ICD-10 Finland
Ulceration of vulva
22.7
19.0
27
13
N90.4
ICD-10 Finland
Leukoplakia of vulva
41.3
18.8
23
6
LEB30
NOMESCO Finland
Destruction of lesion of vaginal mucosa
22.6
16.2
23
11
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.0
15.2
24
37
N90.3
ICD-10 Finland
Dysplasia of vulva, unspecified
+∞
14.7
14
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.5
14.4
58
195
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
6.7
14.0
23
37
D06BB04
ATC
podophyllotoxin; topical
4.9
13.7
32
72
N90.9
ICD-10 Finland
Noninflammatory disorder of vulva and perineum, unspecified
25.7
12.6
17
7
C51.01
ICD-10 Finland
Squamous cell carcinoma of the labium majus
+∞
12.6
12
*
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
9.7
12.5
25
28
N90.8
ICD-10 Finland
Other specified noninflammatory disorders of vulva and perineum
13.2
12.3
21
17
N87.1
ICD-10 Finland
Moderate cervical dysplasia
9.9
11.7
23
25
N89.2
ICD-10 Finland
Severe vaginal dysplasia, not elsewhere classified
67.7
11.7
13
*
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.1
11.2
20
35
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.8
11.0
66
277
N89.1
ICD-10 Finland
Moderate vaginal dysplasia
29.3
10.8
14
5
2333B
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Other and unspecified female genital organs[CARCINOMA IN SITU VULVAE]
+∞
10.5
10
*
N89.0
ICD-10 Finland
Mild vaginal dysplasia
17.5
10.0
15
9
B01AB10
ATC
tinzaparin; parenteral
2.9
9.5
49
189
8474
FHL
Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia
19.3
9.0
13
7
J02AC01
ATC
fluconazole; systemic
2.1
8.9
176
1213
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
11.2
8.9
16
15
P01AB01
ATC
metronidazole; oral, rectal
2.1
8.6
160
1074
ZXC10
NOMESCO Finland
Use of laser
5.1
8.5
18
37
WX002
NOMESCO Finland
Sedation and analgesia
2.3
8.4
79
407
8077/2-C51.1
ICD-O-3
Squamous intraepithelial neoplasia, high grade of labium minus
+∞
8.4
8
*
LWA00
NOMESCO Finland
Repair of wound dehiscence in gynaecological surgery
+∞
8.4
8
*
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
7.3
7.9
18
26
WZC00
NOMESCO Finland
Treatment plan or consultation
2.0
7.5
122
769
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
3.9
7.3
22
60
E0000UV, ,
ATC
1.9
7.3
147
997
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.5
7.1
25
76
WX320
NOMESCO Finland
Spinalanesthesy
2.1
7.1
93
541
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.2
6.8
27
89
TQW40
NOMESCO Finland
Remowal of suture of skin
2.9
6.8
32
117
C51.11
ICD-10 Finland
Squamous cell carcinoma of the labium minus
41.0
6.8
8
*
D06BB03
ATC
aciclovir; topical
3.1
6.3
27
93
LFC96
NOMESCO Finland
Other partial excision of vulva or perineum
+∞
6.3
6
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.7
6.2
34
135
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
6.1
137
944
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
43
17
29.46
62.56
3.1
1.6
—
—
—
0
0
81
128
8.35
52.12
2.9
1.5
—
—
—
0
0
181
660
5.53
46.97
2.7
1.4
—
—
—
0
0
193
1228
2.66
14.22
2.8
2.4
—
—
—
0
0
110
614
2.26
9.84
2.2
2.0
—
—
—
0
0
151
1046
1.91
6.89
6.0
3.7
35.69
36.12
g/l
0.47
142
975
183
1369
1.89
6.40
6.3
5.4
10.23
9.70
umol/l
0.36
173
1292
106
678
1.88
5.99
3.7
2.9
0.16
0.44
e6/l
2.32
89
500
149
1079
1.77
5.47
21.2
10.4
1.27
1.14
inr
0.85
41
342
156
1151
1.76
5.32
5.8
4.9
1.22
1.22
mmol/l
0.22
138
1043
192
1508
1.79
5.22
10.2
8.8
4.01
3.92
e9/l
0.26
174
1323
100
652
1.81
5.18
3.0
2.9
997.77
933.97
ng/l
0.07
85
555
53
281
2.08
5.06
2.7
2.1
8.41
6.43
umol/l
0.33
46
246
84
523
1.85
5.04
1.7
1.5
—
—
—
0
0
168
1278
1.73
5.03
6.8
5.6
1.22
1.23
mmol/l
0.80
136
1078
124
869
1.74
4.98
3.9
3.0
—
—
—
0
0
234
1972
1.91
4.82
9.4
7.0
81.89
77.19
u/l
0.63
228
1842
178
1415
1.65
4.20
4.8
4.0
6.60
6.44
mmol/l
0.50
171
1304
22
86
2.68
4.16
1.3
2.4
2.11
1.49
g/l
1.15
16
74
112
794
1.66
4.14
3.5
2.1
55.80
58.07
u/l
0.30
104
728
33
157
2.24
4.13
1.6
1.5
—
—
—
0
0
159
1232
1.63
4.12
8.1
5.5
27.59
29.26
%
1.17
154
1149
165
1291
1.63
4.11
4.4
3.8
0.00
0.01
estimate
0.50
37
252
25
107
2.46
3.95
5.2
3.7
2.38
1.87
mmol/l
0.28
20
84
285
2669
3.21
3.94
21.6
14.6
73.46
68.73
umol/l
1.11
285
2669
163
1280
1.61
3.93
5.4
5.1
0.00
0.00
estimate
0.50
36
251
156
1217
1.60
3.83
7.5
5.3
58.41
56.26
%
1.48
149
1132
51
300
1.85
3.59
2.3
2.0
—
—
—
0
0
100
711
1.62
3.56
5.2
3.6
18.50
5.81
mg/mmol
0.98
65
400
57
357
1.74
3.26
2.1
1.8
—
—
—
0
0
265
2416
1.98
3.13
17.6
11.7
80.29
81.57
ml/min/173m2
0.41
243
1971
264
2414
1.92
2.94
4.2
3.9
1.32
1.24
mmol/l
1.02
243
2224
65
434
1.64
2.92
3.7
3.8
112.93
165.20
ng/l
0.25
43
314
238
2120
1.64
2.84
5.4
4.5
14.84
14.70
pmol/l
0.44
218
1946
31
168
1.94
2.80
2.2
3.2
195.00
211.21
ng/l
0.08
26
154
14
54
2.67
2.74
3.7
1.7
121.89
131.51
g/l
—
9
37
130
1028
1.47
2.70
2.0
2.0
103.97
99.14
pmol/l
0.33
53
486
273
2540
2.05
2.64
20.5
12.6
21.66
19.91
mg/l
0.39
229
1976
10
30
3.41
2.63
1.7
2.3
—
—
u/ml
—
0
0
9
25
3.68
2.59
1.0
1.2
—
—
—
0
0
8
20
4.08
2.58
1.1
1.2
—
—
—
0
0
15
62
2.50
2.58
1.1
1.2
—
—
—
0
0
48
307
1.67
2.54
3.9
4.3
32.91
33.13
%
0.04
32
199
64
442
1.57
2.49
1.6
1.7
1183.51
1183.51
nmol/l
0.00
49
325
37
221
1.77
2.49
4.5
6.1
0.18
1.47
mmol/l
1.10
26
185
8
21
3.89
2.48
1.1
1.0
—
—
—
0
0
58
392
1.60
2.47
3.1
2.6
1.26
1.05
e6/l
0.17
41
204
153
1268
1.43
2.39
4.3
3.8
0.00
0.00
estimate
-0.00
36
273
10
33
3.10
2.38
1.0
1.3
—
—
—
0
0
115
906
1.44
2.36
3.8
3.1
2.37
2.36
mmol/l
0.29
101
805
14
59
2.44
2.33
1.1
1.9
—
—
—
0
0
194
1684
1.45
2.32
3.9
2.9
53.18
42.08
u/l
0.90
184
1573
6
13
4.69
2.28
1.5
2.6
—
—
—
0
0
41
259
1.68
2.28
2.0
1.4
1.38
1.32
%
0.30
36
230
19
93
2.12
2.27
1.9
1.8
—
—
—
0
0
255
2346
1.66
2.27
6.4
5.4
39.21
39.09
mmol/mol
0.08
240
2190
273
2561
1.92
2.24
5.5
4.9
2.70
2.85
mmol/l
1.92
251
2375
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
48
2.56
2.21
1.4
2.5
0.31
0.39
u/ml
—
7
29
8
25
3.26
2.11
1.1
1.1
—
—
—
0
0
105
828
1.42
2.10
4.2
2.8
30.94
29.02
u/l
0.45
98
793
5
10
5.06
2.08
1.8
2.3
—
—
—
0
0
265
2475
1.72
2.06
5.3
4.4
5.87
5.82
mmol/l
0.26
245
2273
17
83
2.11
2.05
1.6
1.3
10.66
3.20
u/ml
—
5
15
6
15
4.06
2.05
2.3
1.6
680.17
746.13
e6/l
—
6
15
22
119
1.92
2.03
11.9
4.8
25.32
25.32
mmol/l
0.00
22
119
42
276
1.61
2.01
2.4
1.8
—
—
—
0
0
14
64
2.25
1.97
1.1
1.2
—
—
—
0
0
8
27
3.02
1.95
1.1
1.6
—
—
—
0
0
13
58
2.30
1.93
1.8
2.2
—
—
—
0
0
13
58
2.30
1.93
1.5
1.4
—
—
—
0
0
216
1944
1.42
1.89
5.9
4.2
13.88
11.85
mm/h
1.29
203
1783
88
686
1.40
1.85
4.7
4.1
0.00
0.00
estimate
0.50
37
259
6
17
3.58
1.84
1.5
1.5
—
—
—
0
0
78
596
1.42
1.84
2.9
2.2
3.47
3.16
mg/l
0.39
62
507
9
35
2.62
1.81
1.3
1.2
—
—
—
0
0
11
47
2.39
1.80
19.5
2.7
5.25
4.99
kpa
0.45
11
47
17
88
1.99
1.79
1.8
1.7
—
—
—
0
0
7
24
2.96
1.73
1.3
1.2
—
—
—
0
0
5
13
3.89
1.72
1.2
1.5
—
—
—
0
0
5
13
3.89
1.72
1.2
1.5
—
—
—
0
0
5
13
3.89
1.72
1.2
1.5
—
—
—
0
0
137
1158
1.34
1.72
2.3
2.3
84.45
78.63
nmol/l
1.41
120
1036
12
55
2.23
1.69
5.5
3.8
54.33
57.95
%
0.47
12
55
12
55
2.23
1.69
5.3
3.3
2.96
4.58
e9/l
3.24
12
55
7
25
2.84
1.66
1.1
1.6
—
—
—
0
0
49
351
1.48
1.62
4.1
2.1
12.95
13.60
umol/l
0.24
43
329
43
300
1.51
1.61
4.5
2.2
24.87
22.03
%
0.69
37
256
8
32
2.54
1.61
1.7
1.7
—
—
—
0
0
51
369
1.46
1.60
3.3
2.8
3.71
3.87
e6/l
0.05
35
181
261
2457
1.55
1.60
6.4
5.3
1.67
2.34
mu/l
0.75
244
2265
76
595
1.37
1.54
1.6
1.7
0.78
0.87
mg/l
0.25
59
449
265
2511
1.56
1.48
4.8
4.3
1.55
1.60
mmol/l
1.02
246
2332
76
599
1.36
1.48
1.3
1.5
26.15
22.53
nmol/l
0.84
65
504
9
38
2.41
1.47
1.8
1.7
—
—
—
0
0
28
181
1.60
1.46
1.9
1.8
—
—
—
0
0
38
264
1.50
1.46
2.7
2.1
28.80
28.23
u/l
0.09
30
221
7
28
2.54
1.46
1.9
1.6
—
—
—
0
0
266
2524
1.57
1.46
4.9
4.4
4.72
4.86
mmol/l
1.48
248
2354
9
39
2.35
1.44
1.3
1.3
—
—
—
0
0
7
29
2.45
1.40
1.1
1.5
—
—
—
0
0
11
54
2.08
1.34
1.5
1.6
—
—
—
0
0
17
98
1.78
1.34
3.0
1.7
—
—
—
0
0
75
599
1.34
1.33
2.8
2.5
14769.55
7643.52
umol/l
0.29
69
528
8
34
2.39
1.30
1.1
1.6
—
—
—
0
0
5
18
2.81
1.29
2.8
2.0
—
—
—
0
0
106
893
1.29
1.28
3.8
3.4
53.95
25.56
ng/l
0.38
69
581
22
139
1.63
1.27
1.7
1.7
—
—
—
0
0
10
49
2.08
1.23
1.7
1.7
—
—
—
0
0
14
78
1.83
1.23
1.2
1.3
392.25
285.14
ug/g
—
8
43
60
473
1.34
1.16
3.7
2.6
2.46
2.45
mmol/l
0.33
52
420
181
1643
1.26
1.15
3.2
3.2
—
—
—
0
0
5
20
2.52
1.15
1.8
1.4
14.80
22.53
ug/l
—
5
20
5
20
2.52
1.15
1.0
1.4
—
—
—
0
0
34
245
1.44
1.12
3.6
3.2
—
—
—
0
0
5
21
2.40
1.09
2.0
1.8
—
—
—
0
0
5
21
2.40
1.09
2.0
1.8
—
—
—
0
0
21
137
1.57
1.09
1.4
1.4
—
—
—
0
0
34
249
1.41
1.03
2.3
1.8
—
—
—
0
0
40
302
1.38
1.03
9.6
6.2
—
—
—
0
0
16
99
1.65
1.02
1.4
1.4
336.29
252.66
miu/ml
—
7
53
7
35
2.02
1.00
1.7
1.6
—
—
—
0
0
7
35
2.02
1.00
1.7
1.6
—
—
—
0
0
62
503
1.29
0.99
1.7
1.7
456.25
15534444.68
pmol/l
0.50
51
412
15
92
1.66
0.99
3.5
2.1
2213.92
350.02
u/l
—
6
34
6
27
2.25
0.94
2.2
1.9
—
16.48
—
0
9
10
55
1.85
0.93
1.6
1.3
—
—
—
0
0
22
152
1.48
0.91
1.0
1.0
—
—
—
0
0
33
247
1.38
0.90
2.2
1.8
—
—
—
0
0
15
95
1.61
0.89
1.1
1.1
—
—
—
0
0
6
30
2.02
0.87
2.0
2.1
—
—
—
0
0
17
112
1.55
0.87
5.9
7.0
91.88
94.29
%
0.96
17
112
15
96
1.59
0.86
1.1
1.1
—
—
—
0
0
6
31
1.95
0.85
1.0
1.0
—
—
—
0
0
22
158
1.42
0.77
1.2
1.3
—
—
—
0
0
5
24
2.10
0.75
1.0
1.1
—
—
—
0
0
110
983
1.19
0.72
4.5
3.8
—
—
—
0
0
130
1184
1.18
0.68
3.4
2.8
108.67
81.39
ug/l
1.07
115
1099
5
29
1.74
0.64
1.0
1.1
—
—
—
0
0
10
63
1.61
0.62
2.0
1.7
172.30
160.40
ug/l
—
10
56
10
63
1.61
0.62
1.2
1.2
—
—
—
0
0
8
50
1.62
0.62
2.1
1.2
—
—
—
0
0
8
50
1.62
0.62
2.1
1.2
—
—
—
0
0
5
30
1.68
0.61
1.4
1.3
—
—
—
0
0
8
54
1.49
0.57
1.5
1.1
3.95
3.75
mmol/l
—
8
48
17
125
1.38
0.55
1.2
1.3
—
—
—
0
0
11
75
1.48
0.51
1.2
2.1
—
—
—
0
0
10
67
1.51
0.50
3.1
1.3
—
—
—
0
0
14
102
1.39
0.48
5.7
1.4
1.20
1.22
g/l
0.08
14
97
27
220
1.25
0.45
6.8
3.8
1.21
1.24
mmol/l
0.95
21
189
10
71
1.42
0.39
1.0
1.3
—
—
—
0
0
5
35
1.44
0.39
2.0
1.3
—
—
—
0
0
5
36
1.40
0.38
2.0
1.3
—
—
—
0
0
5
36
1.40
0.38
2.0
1.3
—
—
—
0
0
5
37
1.36
0.37
2.0
1.3
—
—
—
0
0
5
37
1.36
0.37
2.0
1.3
—
—
—
0
0
5
37
1.36
0.37
2.0
1.3
—
—
—
0
0
26
217
1.22
0.37
2.0
2.6
49.89
67.48
ml/min/173m2
—
9
89
12
90
1.35
0.36
1.6
1.8
—
—
—
0
0
10
73
1.38
0.35
1.5
1.7
—
232.00
—
0
5
27
230
1.19
0.32
2.0
2.9
63.78
70.60
u/ml
0.05
27
220
48
533
0.88
0.31
1.4
1.3
2.47
10.25
u/ml
2.48
16
209
19
227
0.83
0.29
1.6
1.6
—
—
—
0
0
8
110
0.72
0.29
4.4
2.0
1.46
1.13
%
—
8
110
60
549
1.12
0.29
5.1
4.0
1.01
1.02
kg/l
—
10
74
10
129
0.77
0.28
1.4
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
79
745
1.08
0.21
1.8
1.6
1.48
1.36
mmol/l
0.49
70
627
8
105
0.76
0.21
4.4
2.0
0.69
0.66
%
—
8
105
0
12
0.00
0.21
0.0
1.2
—
8.67
—
0
12
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
14
119
1.19
0.18
1.7
2.5
0.17
0.19
e6/l
0.04
14
114
21
186
1.14
0.17
1.5
1.3
—
44.96
—
0
10
8
70
1.15
0.16
1.3
1.3
—
—
—
0
0
8
71
1.13
0.16
2.0
1.5
—
0.31
—
0
7
68
650
1.06
0.13
1.3
1.3
0.72
1.57
u/ml
—
10
176
12
105
1.15
0.11
6.1
2.5
24.40
25.62
mmol/l
0.69
12
105
14
128
1.10
0.07
1.2
1.6
—
—
—
0
0
24
227
1.06
0.06
1.0
1.2
123.92
162.85
iu/ml
—
5
105
55
537
1.03
0.04
1.4
1.3
21.46
32.01
iu/ml
0.56
14
185
10
92
1.09
0.03
1.7
1.7
—
—
—
0
0
10
98
1.02
0.00
1.4
2.2
—
—
—
0
0
26
265
0.98
0.00
3.2
4.0
3.92
9.88
ug/l
1.45
21
213
7
75
0.93
0.00
1.3
1.4
—
—
—
0
0
6
66
0.91
0.00
2.2
1.3
—
—
—
0
0
5
51
0.98
0.00
1.6
1.3
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
0.00
0.0
1.0
—
140.78
—
0
9
7
75
0.93
0.00
1.3
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
7
75
0.93
0.00
1.3
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
93.00
—
0
7
7
72
0.97
-0.00
1.1
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
10
100
1.00
-0.00
7.5
3.2
46.68
45.91
%
—
10
100
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
80
1.00
-0.00
1.6
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_VULVA – Carcinoma in situ of vulva
GWS hits: 2
This endpoint is excluded from FinRegistry analyses (omitted endpoint).